Greytown Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Greytown Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.75M	Buy	12,740 +206	+2%	+$27.5K	1.03%	20
2024 Q1	$1.72M	Sell	12,534 -448	-3%	-$61.2K	0.97%	21
2023 Q4	$1.76M	Sell	12,982 -878	-6%	-$107K	0.94%	22
2023 Q3	$1.7M	Buy	13,860 +696	+5%	+$88.5K	0.94%	22
2023 Q2	$1.67M	Sell	13,164 -20,024	-60%	-$2.6M	0.91%	19
2023 Q1	$4.29M	Buy	33,188 +634	+2%	+$83K	2.22%	13
2022 Q4	$4.27M	Buy	32,554 +127	+0.4%	+$16.4K	2.32%	12
2022 Q3	$3.79M	Buy	32,427 +9,539	+42%	+$1.18M	2.29%	12
2022 Q2	$2.69M	Buy	22,888 +10,236	+81%	+$1.22M	1.53%	16
2022 Q1	$1.65M	Buy	+12,652	New	+$1.65M	0.8%	22

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Greytown Advisors's IBB Position: Q2 2024 in Review

Greytown Advisors increased its iShares Biotechnology ETF (IBB) stake by 1.6% in Q2 2024, buying an estimated $27.5K and bringing the position to 12,740 shares worth $1.75M. The position accounts for 1.03% of the portfolio, ranked #20.

Greytown Advisors first reported a position in IBB in Q1 2022 and has held it in 10 quarters since. The position peaked at $4.29M in Q1 2023. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

Greytown Advisors held 12,740 shares of iShares Biotechnology ETF worth $1.75M as of Q2 2024.
Greytown Advisors bought 206 iShares Biotechnology ETF shares in Q2 2024, an estimated $27.5K.
iShares Biotechnology ETF made up 1.03% of Greytown Advisors's portfolio in Q2 2024, its #20 holding.
Greytown Advisors first reported a position in iShares Biotechnology ETF in Q1 2022 and has held it in 10 quarters since.
Greytown Advisors's iShares Biotechnology ETF position peaked at $4.29M in Q1 2023.
894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Greytown Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.